TolerogenixX GmbH

Im Neuenheimer Feld 162, 69120 Heidelberg, DEU

Master Data

Basic information of the organization

Registry

Registered

12/13/2016

IndustryClassified using Destatis WZ standard, derived from commercial register and web data by Fusionbase AI.

Research and experimental development on biotechnologyResearch and experimental development on biotechnologyWZ 72.10.1PrimaryMedical laboratory activitiesMedical laboratory activitiesWZ 86.91.2Research and experimental development on social sciences and humanitiesResearch and experimental development on social sciences and humanitiesWZ 72.20.0

Purpose

Erforschung von biochemischen und molekularbiologischen Wirkmechanismen und die Entwicklung von biochemischen, molekularbiologischen und biotechnologischen Verfahren zur Gewinnung neuer Diagnostika sowie neuer Wirkstoffe, Medikamente und Zelltherapeutika sowie deren Entwicklung und Vermarktung.

History

Changes published in the official company registry

No events found for this filter

Management

Legal representatives of the organization

Name	Role	Entry Date
Matthias Prof. Dr. Schaier since 12/13/2016	Managing Director	12/13/2016

Beneficial Owners

Natural persons who ultimately own or control the company, resolved through the shareholder chain

Beneficial owner data is only accessible to registered users.

Shareholders

Company ownership and partner structure

13 shareholders

GmbH structure

2 of 13 shown

DB Speciality Invest GmbH & Co. KG

Germany

€13,216

25.03%

High-Tech Gründerfonds II GmbH & Co. KG

Germany

€5,715

10.82%

News & Media Coverage

Insolvency Notices

Real-time check for insolvency notices from register courts

Current insolvency proceedings

Check if there are any insolvency proceedings for this company

Commercial Register Documents

Real-time document download from the commercial register

Shareholder List

Current Print (Aktueller Abdruck)

Chronological Print (Chronologischer Abdruck)